APA (7th ed.) Citation

A, M., S, S., P, D., S, R., K, I., H, P., . . . K, H. (2025). Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: A meta-analysis of efficacy and safety outcomes. American heart journal plus : cardiology research and practice, 59, 100607. https://doi.org/10.1016/j.ahjo.2025.100607

Chicago Style (17th ed.) Citation

A, Mousavi, et al. "Direct Oral Anticoagulants Versus Low-molecular-weight Heparin for Thromboprophylaxis in Cancer-related Surgeries: A Meta-analysis of Efficacy and Safety Outcomes." American Heart Journal Plus : Cardiology Research and Practice 59 (2025): 100607. https://doi.org/10.1016/j.ahjo.2025.100607.

MLA (9th ed.) Citation

A, Mousavi, et al. "Direct Oral Anticoagulants Versus Low-molecular-weight Heparin for Thromboprophylaxis in Cancer-related Surgeries: A Meta-analysis of Efficacy and Safety Outcomes." American Heart Journal Plus : Cardiology Research and Practice, vol. 59, 2025, p. 100607, https://doi.org/10.1016/j.ahjo.2025.100607.